- Home
- OLMA vs OABI Comparison
OLMA vs OABI Comparison
Compare OLMA & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- OABI
- Stock Information
- Founded
- OLMA 2006
- OABI 2012
- Country
- OLMA United States
- OABI United States
- Employees
- OLMA 88
- OABI N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- OLMA Health Care
- OABI Health Care
- Exchange
- OLMA Nasdaq
- OABI Nasdaq
- Market Cap
- OLMA 465.4M
- OABI 490.1M
- IPO Year
- OLMA 2020
- OABI N/A
- Fundamental
- Price
- OLMA $5.92
- OABI $3.74
- Analyst Decision
- OLMA Strong Buy
- OABI Strong Buy
- Analyst Count
- OLMA 5
- OABI 4
- Target Price
- OLMA $26.25
- OABI $9.00
- AVG Volume (30 Days)
- OLMA 1.0M
- OABI 431.5K
- Earning Date
- OLMA 11-12-2024
- OABI 11-12-2024
- Dividend Yield
- OLMA N/A
- OABI N/A
- EPS Growth
- OLMA N/A
- OABI N/A
- EPS
- OLMA N/A
- OABI N/A
- Revenue
- OLMA N/A
- OABI $20,409,000.00
- Revenue This Year
- OLMA N/A
- OABI N/A
- Revenue Next Year
- OLMA N/A
- OABI $77.16
- P/E Ratio
- OLMA N/A
- OABI N/A
- Revenue Growth
- OLMA N/A
- OABI N/A
- 52 Week Low
- OLMA $6.10
- OABI $3.56
- 52 Week High
- OLMA $16.78
- OABI $6.72
- Technical
- Relative Strength Index (RSI)
- OLMA 23.84
- OABI 43.35
- Support Level
- OLMA $6.25
- OABI $3.71
- Resistance Level
- OLMA $6.87
- OABI $4.17
- Average True Range (ATR)
- OLMA 0.82
- OABI 0.15
- MACD
- OLMA -0.34
- OABI -0.01
- Stochastic Oscillator
- OLMA 0.00
- OABI 25.00
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.